Jonathan Stuart Kaplan
Examiner (ID: 15168)
Most Active Art Unit | 2836 |
Art Unit(s) | 2107, 2104, 2836 |
Total Applications | 226 |
Issued Applications | 203 |
Pending Applications | 10 |
Abandoned Applications | 13 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5534062
[patent_doc_number] => 20090233850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions'
[patent_app_type] => utility
[patent_app_number] => 11/756567
[patent_app_country] => US
[patent_app_date] => 2007-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14279
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20090233850.pdf
[firstpage_image] =>[orig_patent_app_number] => 11756567
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/756567 | CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions | May 30, 2007 | Issued |
Array
(
[id] => 5091688
[patent_doc_number] => 20070231327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Anti-CCR5 antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/805573
[patent_app_country] => US
[patent_app_date] => 2007-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14905
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231327.pdf
[firstpage_image] =>[orig_patent_app_number] => 11805573
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/805573 | Anti-CCR5 antibodies | May 22, 2007 | Abandoned |
Array
(
[id] => 4681817
[patent_doc_number] => 20080248043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Antibodies to SARS coronavirus'
[patent_app_type] => utility
[patent_app_number] => 11/805129
[patent_app_country] => US
[patent_app_date] => 2007-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 35332
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248043.pdf
[firstpage_image] =>[orig_patent_app_number] => 11805129
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/805129 | Antibodies to SARS coronavirus | May 20, 2007 | Issued |
Array
(
[id] => 5084935
[patent_doc_number] => 20070274986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Compositions comprising anti-CCR5 antibody'
[patent_app_type] => utility
[patent_app_number] => 11/804746
[patent_app_country] => US
[patent_app_date] => 2007-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14909
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20070274986.pdf
[firstpage_image] =>[orig_patent_app_number] => 11804746
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/804746 | Compositions comprising anti-CCR5 antibody | May 16, 2007 | Abandoned |
Array
(
[id] => 195517
[patent_doc_number] => 07635476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-22
[patent_title] => 'Anti-hepatitis a virus antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/789377
[patent_app_country] => US
[patent_app_date] => 2007-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18288
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/635/07635476.pdf
[firstpage_image] =>[orig_patent_app_number] => 11789377
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/789377 | Anti-hepatitis a virus antibodies | Apr 22, 2007 | Issued |
Array
(
[id] => 6487684
[patent_doc_number] => 20100009341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'METHODS AND MEANS FOR ASSESSING HIV GAG/PROTEASE INHIBITOR THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/296987
[patent_app_country] => US
[patent_app_date] => 2007-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9565
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20100009341.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296987
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296987 | METHODS AND MEANS FOR ASSESSING HIV GAG/PROTEASE INHIBITOR THERAPY | Apr 12, 2007 | Abandoned |
Array
(
[id] => 5247353
[patent_doc_number] => 20070243587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus'
[patent_app_type] => utility
[patent_app_number] => 11/783300
[patent_app_country] => US
[patent_app_date] => 2007-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7992
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20070243587.pdf
[firstpage_image] =>[orig_patent_app_number] => 11783300
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/783300 | Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus | Apr 8, 2007 | Abandoned |
Array
(
[id] => 7555111
[patent_doc_number] => 08067011
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'Compositions and methods for treating B-cell malignancies'
[patent_app_type] => utility
[patent_app_number] => 11/697945
[patent_app_country] => US
[patent_app_date] => 2007-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11191
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067011.pdf
[firstpage_image] =>[orig_patent_app_number] => 11697945
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/697945 | Compositions and methods for treating B-cell malignancies | Apr 8, 2007 | Issued |
Array
(
[id] => 5354681
[patent_doc_number] => 20090186025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'Fusion Protein Comprising an Fc Receptor Binding Polypeptide and an Antigenic Polypeptide for Mediating an Immune Response'
[patent_app_type] => utility
[patent_app_number] => 12/225454
[patent_app_country] => US
[patent_app_date] => 2007-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15856
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186025.pdf
[firstpage_image] =>[orig_patent_app_number] => 12225454
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225454 | Fusion Protein Comprising an Fc Receptor Binding Polypeptide and an Antigenic Polypeptide for Mediating an Immune Response | Mar 21, 2007 | Abandoned |
Array
(
[id] => 5177503
[patent_doc_number] => 20070178563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Mosaic infectious bursal disease virus vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/717293
[patent_app_country] => US
[patent_app_date] => 2007-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 42960
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20070178563.pdf
[firstpage_image] =>[orig_patent_app_number] => 11717293
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/717293 | Mosaic infectious bursal disease virus vaccines | Mar 11, 2007 | Abandoned |
Array
(
[id] => 6302366
[patent_doc_number] => 20100068213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'SELECTED COLOSTRUM FOR TREATMENT OF INTESTINAL BARRIER FUNCTION DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/527772
[patent_app_country] => US
[patent_app_date] => 2007-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3783
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068213.pdf
[firstpage_image] =>[orig_patent_app_number] => 12527772
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/527772 | SELECTED COLOSTRUM FOR TREATMENT OF INTESTINAL BARRIER FUNCTION DISORDERS | Feb 19, 2007 | Abandoned |
Array
(
[id] => 4824775
[patent_doc_number] => 20080124272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Influenza antibodies, compositions, and related methods'
[patent_app_type] => utility
[patent_app_number] => 11/707257
[patent_app_country] => US
[patent_app_date] => 2007-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 28454
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20080124272.pdf
[firstpage_image] =>[orig_patent_app_number] => 11707257
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/707257 | Influenza antibodies, compositions, and related methods | Feb 12, 2007 | Abandoned |
Array
(
[id] => 6603015
[patent_doc_number] => 20100292445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'Method for Efficient Purification of Bionanocapsule'
[patent_app_type] => utility
[patent_app_number] => 12/223864
[patent_app_country] => US
[patent_app_date] => 2007-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5649
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292445.pdf
[firstpage_image] =>[orig_patent_app_number] => 12223864
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/223864 | Method for Efficient Purification of Bionanocapsule | Feb 8, 2007 | Abandoned |
Array
(
[id] => 5100803
[patent_doc_number] => 20070184065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Compositions and Methods for Inhibiting Viral Adhesion'
[patent_app_type] => utility
[patent_app_number] => 11/627548
[patent_app_country] => US
[patent_app_date] => 2007-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9012
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20070184065.pdf
[firstpage_image] =>[orig_patent_app_number] => 11627548
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/627548 | Compositions and Methods for Inhibiting Viral Adhesion | Jan 25, 2007 | Abandoned |
Array
(
[id] => 5452600
[patent_doc_number] => 20090068637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'MONOCLONAL ANTIBODIES BINDING TO AVIAN INFLUENZA VIRUS SUBTYPE H5 HAEMAGGLUTININ AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/162343
[patent_app_country] => US
[patent_app_date] => 2007-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 38530
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20090068637.pdf
[firstpage_image] =>[orig_patent_app_number] => 12162343
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/162343 | MONOCLONAL ANTIBODIES BINDING TO AVIAN INFLUENZA VIRUS SUBTYPE H5 HAEMAGGLUTININ AND USE THEREOF | Jan 25, 2007 | Abandoned |
Array
(
[id] => 5253335
[patent_doc_number] => 20070134791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Cells for detection of enteroviruses'
[patent_app_type] => utility
[patent_app_number] => 11/657822
[patent_app_country] => US
[patent_app_date] => 2007-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17974
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134791.pdf
[firstpage_image] =>[orig_patent_app_number] => 11657822
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/657822 | Cells for detection of enteroviruses | Jan 22, 2007 | Issued |
Array
(
[id] => 5367124
[patent_doc_number] => 20090304683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Soluble Fragments of The Sars-Cov Spike Glycoprotein'
[patent_app_type] => utility
[patent_app_number] => 12/087306
[patent_app_country] => US
[patent_app_date] => 2007-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 32413
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304683.pdf
[firstpage_image] =>[orig_patent_app_number] => 12087306
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/087306 | Soluble Fragments of The Sars-Cov Spike Glycoprotein | Jan 18, 2007 | Abandoned |
Array
(
[id] => 4670394
[patent_doc_number] => 20080045454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 11/650384
[patent_app_country] => US
[patent_app_date] => 2007-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14791
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045454.pdf
[firstpage_image] =>[orig_patent_app_number] => 11650384
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/650384 | Polynucleotide encoding a TRIM-Cyp polypeptide, compositions thereof, and methods of using same | Jan 4, 2007 | Issued |
Array
(
[id] => 4455510
[patent_doc_number] => 07892754
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/641066
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 5556
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/892/07892754.pdf
[firstpage_image] =>[orig_patent_app_number] => 11641066
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/641066 | Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof | Dec 18, 2006 | Issued |
Array
(
[id] => 8189596
[patent_doc_number] => 08183352
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Attenuated vif DNA immunization cassettes for genetic vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/639542
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 21
[patent_no_of_words] => 13410
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/183/08183352.pdf
[firstpage_image] =>[orig_patent_app_number] => 11639542
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/639542 | Attenuated vif DNA immunization cassettes for genetic vaccines | Dec 14, 2006 | Issued |